Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Expected weight loss: Minimal (01 kg) 0.5 mg Weeks 58 First therapeutic dose
MAPK Pathway Modulation p38 MAPK pathway suppression significantly inhibits LPS-induced phosphorylation, reducing inflammatory response and cellular stress
By binding copper and coordinating anti-inflammatory, antioxidative, pro-angiogenic, and extracellular matrix (ECM) remodeling pathways while potentially reducing follicular DHT through copper-sensitive type 1 5-reductase inhibition it establishes optimal conditions for sustained anagen growth and a healthier scalp environment
Topical is sufficient and has the most clinical evidence
It may help repair neuroinflammation and restore gut-brain axis balance, which are important considerations given the emerging link between gut health and mental health in addiction recovery (Sikiric et al, 2018)
